feed,title,long_url,short_url
Benzinga,"Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy",https://benzinga.com/general/biotech/23/10/35295139/mixed-signals-for-crispr-therapeutics-analyst-weighs-barriers-potential-sales-for-sickle-cell-the,https://da.gd/q7Jhp
Benzinga,Here's How Much You Would Have Made Owning Old Dominion Freight Line Stock In The Last 20 Years,https://benzinga.com/news/23/10/35295726/heres-how-much-you-would-have-made-owning-old-dominion-freight-line-stock-in-the-last-20-years,https://da.gd/GPMr9O
Benzinga,Here's How Much $1000 Invested In Seagen 5 Years Ago Would Be Worth Today,https://benzinga.com/news/23/10/35295725/heres-how-much-1000-invested-in-seagen-5-years-ago-would-be-worth-today,https://da.gd/i7JCSi
